drugset / Trial / NCT00078611
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to evaluate natalizumab in individuals with moderately to severely active Crohn's Disease.
Timeline
- Start
- 2004-03
- Primary completion
- 2005-03
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | natalizumab | Monoclonal antibody | — | Intravenous |